Summa Equity is to sell HyTest, a developer and producer of antibodies and antigens, to Mindray, a global medical technology company, for total consideration of approximately EUR545 million. Since Summa Equity’s acquisition of HyTest in 2018, the company has continued to develop its industry leading antibodies and antigens product portfolio,
Rarebreed Veterinary Partners (Rarebreed), a technology-enabled veterinary services platform, has closed a new round of financing, led by existing investors Halle Capital Management and Trilantic North America, both leading private equity firms. The investment will be used to support Rarebreed’s continued growth through the acquisition of additional veterinary hospitals and
Medtech start-up Gelmetix, the developer of a first-in-class polymer treatment for chronic lower back pain, has closed a successful GBP5 million Series C equity financing round.
SageTech Medical Equipment Ltd (SageTech) has completed a GBP2.9 million pre-series A investment, including a GBP1.6 million investment introduced by specialist venture capitalist EMV Capital. As part of restructuring the company’s arrangements for the commercialisation of the business, EMV Capital’s parent company NetScientific PLC purchased GBP200,000 of shares, in line
Diaverum, a global renal care service provider, announces today the acquisition of booknowmed.com, the world’s leading booking engine in renal care that enables patients to browse over 400 dialysis clinics across 54 countries and book their dialysis treatment in real-time, with no booking or cancellation fees. With its ‘patient-centric’ approach,
London-based private equity advisory firm ADM Capital Europe’ Cibus Enterprise Fund (Cibus) has invested in the personalised health and wellness company Rem3dy Health Limited, (Remedy Health).
Emmes, a global, full-service Clinical Research Organisation (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation and a portfolio company of Behrman Capital, has acquired Orphan Reach, a CRO specialised in clinical research related to rare diseases. Financial terms of the transaction have not been disclosed. This
By Purva Aggarwal – Warburg Pincus has invested USD110 million into a Series C round for New York-based healthcare tech company Aetion. This round is the latest in a string of similar investments within the health tech space for Warburg Pincus. The global growth equity PE group has poured in
Huma Therapeutics Limited has completed its latest funding round with financing of approximately USD130 million. The investment will scale Huma’s modular platform which can power digital ‘hospitals at home’ nationally, and support the pharmaceutical and research industries to run the largest ever decentralized clinical trials. Huma’s platform combines predictive algorithms,
Cambridge based biotechnology company, Phico Therapeutics (Phico), has received GBP7 million in funding from a consortium of investors. BGF, the UK and Ireland’s most active growth capital investor, led the round with a GBP3 million investment, while a further GBP4 million was received from existing backers. Founded in 2000 by
12 September, 2024 – 6:00 pm
05 June, 2024 – 8:30 am
24 October, 2024 – 8:30 am
14 November, 2024 – 8:00 am
